Birdwatch Note
2023-04-02 03:30:51 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The study linked was published in the journal Cureus, which has been criticized for its low standards and for publishing studies that have not been properly peer-reviewed. The largest reputable study to date has shown that Ivermectin has had no benefit as a COVID-19 treatment. https://www.nejm.org/doi/full/10.1056/NEJMoa2115869
Written by 6DC0C4E00938B2A5C44BE6165747D06D0F6A8FA060D55DDE962100F82E379209
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1566207048014233600
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1642368971906187265
- noteId - 1642368971906187265
- participantId -
- noteAuthorParticipantId - 6DC0C4E00938B2A5C44BE6165747D06D0F6A8FA060D55DDE962100F82E379209 Participant Details
- createdAtMillis - 1680406251299
- tweetId - 1566207048014233600
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The study linked was published in the journal Cureus, which has been criticized for its low standards and for publishing studies that have not been properly peer-reviewed. The largest reputable study to date has shown that Ivermectin has had no benefit as a COVID-19 treatment. https://www.nejm.org/doi/full/10.1056/NEJMoa2115869
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-04-02 03:30:51 UTC (1680406251299) |
1969-12-31 23:59:59 UTC (-1) |
2023-04-03 02:39:46 UTC (1680489586224) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-04-02 11:50:40 -0500 | Rating Details | |
| 2023-04-02 07:52:49 -0500 | Rating Details | |
| 2023-04-02 06:29:53 -0500 | Rating Details | |
| 2023-04-02 06:15:03 -0500 | Rating Details | |
| 2023-04-02 05:51:58 -0500 | Rating Details | |
| 2023-04-02 05:48:57 -0500 | Rating Details | |
| 2023-04-02 01:49:39 -0500 | Rating Details | |
| 2023-04-02 01:05:18 -0500 | Rating Details | |
| 2023-04-02 00:50:22 -0500 | Rating Details | |
| 2023-04-01 23:45:11 -0500 | Rating Details | |
| 2023-04-01 23:28:44 -0500 | Rating Details | |
| 2023-04-01 23:22:17 -0500 | Rating Details | |
| 2023-04-01 23:19:16 -0500 | Rating Details | |
| 2023-04-01 23:02:50 -0500 | Rating Details | |
| 2023-04-01 23:22:17 -0500 | Rating Details | |
| 2023-04-02 07:52:49 -0500 | Rating Details | |
| 2023-04-02 06:15:03 -0500 | Rating Details | |
| 2023-04-02 01:49:39 -0500 | Rating Details | |
| 2023-04-02 01:05:18 -0500 | Rating Details | |
| 2023-04-02 00:50:22 -0500 | Rating Details | |
| 2023-04-01 23:02:50 -0500 | Rating Details | |
| 2023-04-02 05:51:58 -0500 | Rating Details | |
| 2023-04-02 11:50:40 -0500 | Rating Details | |
| 2023-04-01 23:19:16 -0500 | Rating Details | |
| 2023-04-02 06:29:53 -0500 | Rating Details | |
| 2023-04-02 05:48:57 -0500 | Rating Details | |
| 2023-04-01 23:45:11 -0500 | Rating Details | |
| 2023-04-01 23:28:44 -0500 | Rating Details |